Records containing: Meniere's Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-06-29Phase 1b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of SPI-1005 in Meniere's Disease
-
CLINICAL_TRIALS study record update · 2026-04-15A Phase II Placebo Controlled Study of the Effects of Anakinra (Kineret) in Subjects With Corticosteroid-Resistant/Intolerant Meniere's Disease (CR-MD) and Corticosteroid-Resistant/Intolerant Autoimmune Inner Ear Disease Disease (CR-AIED)
-
CLINICAL_TRIALS study record update · 2026-04-08Genetics and Biohumoral Factors in Menière's Disease
-
CLINICAL_TRIALS study record update · 2025-12-26Open-Label Study of SPI-1005 for the Treatment of Meniere's Disease
-
CLINICAL_TRIALS study record update · 2025-12-08Deep Phenotyping of Hearing Instability Disorders: Cohort Establishment, Biomarker Identification, Development of Novel Phenotyping Measures, and Discovery of Therapeutic Targets
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-12-05Pilot Study of Modulating Auditory Symptoms and Vertigo of Meniere's Disease by Non-invasive Mastoid Electric Stimulation: Double-blind, Randomized, Sham-controlled, Investigator-initiated Trial
-
CLINICAL_TRIALS study record update · 2023-12-22Production of a Device to Obtain Continuous Ambulatory Vestibular Assessment (CAVA) - Dizziness Trial
-
CLINICAL_TRIALS study record update · 2023-08-14A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Safety And Efficacy of SPI-1005 in Meniere's Disease
-
CLINICAL_TRIALS study record update · 2023-01-20A 6-Month, Multicenter, Phase 3, Open-Label Extension Safety Study of OTO-104 Given At 3-Month Intervals by Intratympanic Injection in Subjects With Unilateral Meniere's Disease
-
CLINICAL_TRIALS study record update · 2023-01-13A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease
-
CLINICAL_TRIALS study record update · 2023-01-12A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease
-
CLINICAL_TRIALS study record update · 2022-12-14A 6-Month, Multicenter, Phase 3, Open-Label Extension Safety Study of OTO-104 Given At 3-Month Intervals by Intratympanic Injection in Subjects With Unilateral Meniere's Disease
-
CLINICAL_TRIALS study record update · 2022-06-22Lamotrigine for Ménière's Disease: a Double-blind, Placebo-controlled Pilot Study
-
CLINICAL_TRIALS study record update · 2021-04-19Treatment of Hearing Fluctuation in Unilateral Meniere's Disease: A Randomized, Placebo-controlled Clinical Trial of Famciclovir
-
CLINICAL_TRIALS study record update · 2021-03-18Phase 1b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of SPI-1005 in Meniere's Disease
-
CLINICAL_TRIALS study record update · 2021-02-01A Multicentre, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study Of The Efficacy and Safety Of Sildenafil Given For The Acute Treatment Of Meniere's Disease
-
CLINICAL_TRIALS study record update · 2020-11-18Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease
-
CLINICAL_TRIALS study record update · 2018-12-10Cochlear Implantation After Labyrinthectomy or a Translabyrinthine Surgical Approach
-
CLINICAL_TRIALS study record update · 2017-09-15A 1-Year, Phase 2, Open-Label Safety Study of OTO-104 Given at 3-Month Intervals by Intratympanic Injection in Subjects With Unilateral Meniere's Disease
-
CLINICAL_TRIALS study record update · 2017-08-18A 6-Month, Prospective, Randomized, Multicenter, Placebo-Controlled Safety Study of OTO-104 Given at 3-Month Intervals by Intratympanic Injection in Subjects With Unilateral Meniere's Disease Followed by a 6-Month Open-Label Extension
-
CLINICAL_TRIALS study record update · 2016-10-24Effectiveness of Transtympanic Steroids in Unilateral Ménière's Disease: a Randomised Controlled Double-Blind Trial
-
CLINICAL_TRIALS study record update · 2016-03-24A Multicenter, Randomized, Open-label Clinical Study With a Concurrent Control Group to Assess the Effectiveness and Safety of Combined Therapy With Isobide Solution and Meniace Tablets Compared to Monotherapy With Meniace Tablets for Patients With Meniere's Disease
-
CLINICAL_TRIALS study record update · 2016-02-12Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent
-
CLINICAL_TRIALS study record update · 2015-09-03A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 2b Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease
-
CLINICAL_TRIALS study record update · 2012-12-24A Random Controlled Clinical Trial:l Traditional Chinese Diaoshi Jifa Therapy of Meniere's Disease